(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 5.3% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Qiagen Nv's revenue in 2025 is $1,978,214,000.On average, 7 Wall Street analysts forecast QGEN's revenue for 2025 to be $448,973,718,575, with the lowest QGEN revenue forecast at $448,205,036,822, and the highest QGEN revenue forecast at $450,050,050,861. On average, 7 Wall Street analysts forecast QGEN's revenue for 2026 to be $478,270,318,596, with the lowest QGEN revenue forecast at $475,257,833,024, and the highest QGEN revenue forecast at $482,919,753,973.
In 2027, QGEN is forecast to generate $515,520,929,741 in revenue, with the lowest revenue forecast at $509,842,510,028 and the highest revenue forecast at $520,700,306,499.